Human stem cell model to study signal transduction and molecular regulation mechanisms in CML

Chinese Medical Journal

Volumn 114, Issue 7, 2001, Pages 680-684

  Fan, Erjin ^a   Hu, Ying ^a   Zhao, Chunhua ^a  

^a INSTITUTE OF HEMATOLOGY AND BLOOD DISEASES HOSPITAL   (China)

Author keywords

Chronic myeloid leukemia; Cyclin dependent kinase inhibitor; Multidrug resistance; Primary CD34+ cells model

Indexed keywords

ACTIN BINDING PROTEIN; CD34 ANTIGEN; GLYCOPROTEIN P; MUSCLE PROTEIN; TAGLN PROTEIN, MOUSE;

ARTICLE; CHRONIC MYELOID LEUKEMIA; GENE EXPRESSION REGULATION; GENETICS; HEMATOPOIETIC STEM CELL; HUMAN; METABOLISM; ONCOGENE; PATHOLOGY; SIGNAL TRANSDUCTION;

ANTIGENS, CD34; GENE EXPRESSION REGULATION, LEUKEMIC; GENES, ABL; HEMATOPOIETIC STEM CELLS; HUMANS; LEUKEMIA, MYELOID, CHRONIC; MICROFILAMENT PROTEINS; MUSCLE PROTEINS; P-GLYCOPROTEIN; SIGNAL TRANSDUCTION;

EID: 0347140933     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Heisterkamp N, Stam K, Groffen J, et al. Structural organization of the bcr gene and its role in the Ph' translocation. Nature 1985;315:758-762.
2. Rowley J. The Philadelphia chromosome translocation. A paradigm for understanding leukemia. Cancer 1990; 65: 2178-2184.
3. bcr/abl gene of the Philadelphia chromosome. Science 1990;247:824-830.
4. Elefanty AG, Hariharan IK, Cory S. bcr-abl, the hallmark of chronic myeloid leukaemia in man, induces multiple haemopoietic neoplasms in mice. EMBO J 1990;9:1069-1078.
5. Heisterkamp N, Jenster G, ten Hoeve J, et al. Acute leukaemia in bcr/abl transgenic mice. Nature 1990;344:251-253.
6. Kantarjian HM, Smith TL, McCredie KB, et al. Chronic myelogenous leukemia: a multivariate analysis of the associations of patient characteristics and therapy with survival. Blood 1985; 66:1326-1335.
7. Naviaux RK, Costanzi E, Haas M, et al. The pCL vector system: rapid production of helper-free, high-titer, recombinant retroviruses. J Virol 1996;70:5701-5705.
8. Kip, which is relocated to the cell cytoplasm and incapable of regulating cdk2 activity. PNAS U S A 2000; 97: 10538-10543.
9. Cortez D, Stoica G, Pierce JH, et al. The BCR-ABL tyrosine kinase inhibits apoptosis by activating a Ras-dependent signaling pathway. Oncogene 1996;13:2589-2594.
10. Bedi A, Zehnbauer BA, Barber JP, et al. Inhibition of apoptosis by BCR-ABL in chronic myeloid leukemia. Blood 1994; 83: 2038-2044.
11. McGahon A, Bissonnette R, Schmitt M, et al. BCR-ABL maintains resistance of chronic myelogenous leukemia cells to apoptotic cell death. Blood 1994;83:1179-1187.
12. Cambier N, Chopra R, Strasser A, et al. BCR-ABL activates pathways mediating cytokine independence and protection against apoptosis in murine hematopoietic cells in a dose-dependent manner. Oncogene 1998;16:335-348.
13. Maguer-Satta V, Burl S, Liu L, et al. BCR-ABL accelerates C2-ceramide-induced apoptosis. Oncogene 1998;16:237-248.
14. Marley SB, Lewis JL, Scott MA, et al. Evaluation of "discordant maturation" in chronic myeloid leukaemia using cultures of primitive progenitor cells and their production of clonogenic progeny (CFU-GM). Br J Haematol 1996;95:299-305.
15. Clarkson BD, Strife A, Wisniewski D, et al. New understanding of the pathogenesis of CML: a prototype of early neoplasia. Leukemia 1997;11:404-428.
16. Marley SB, Lewis JL, Goldman JM, et al. Abnormal kinetics of colony formation by erythroid burst-forming units (BFU-E) in chronic myeloid leukaemia. Br J Haematol 1996;93:878-883.